Colgate-Palmolive Non-GAAP EPS of $0.97 beats by $0.04, revenue of $5.37B beats by $40M (CL:NYSE)
Colgate-Palmolive reported Q3 Non-GAAP EPS of $0.97, exceeding estimates by $0.04, with revenue of $5.37B, up 4.7% Y/Y and $40M above expectations. Net sales rose 4.6%, while organic sales increased 3.6%, impacted by lower private label pet food sales.
How this was made
The 30-second read
Why it matters
The beat may trigger buying interest from income‑focused investors and could influence sector sentiment.
Market read
Earnings beat is a primary catalyst for the stock and may affect related consumer‑staples equities.
What to watch
Potential margin pressure from higher input costs not disclosed in the brief.
Background
Colgate‑Palmolive’s Q3 earnings release provides the first public disclosure of the latest financial results.
Ticker impact
Colgate-Palmolive reported Q3 Non‑GAAP EPS of $0.97, beating expectations by $0.04 and revenue of $5.37B, up 4.7% YoY, beating by $40M.
likely upward pressure as the market prices in the earnings beat
Both EPS and revenue exceeded consensus, and the beat size is material for a mid‑cap consumer staples company.
Market effects
May lift other consumer‑staples peers as the sector shows resilience.
Positive for U.S. consumer‑goods stocks in early trading.
Limited to U.S. markets; no direct global effect.
Counterpoint
If the beat is already priced in, the stock could face a short‑term pullback.
Key entities
- companyColgate‑Palmolive
Consumer‑staples manufacturer reporting Q3 results.


